Trial of new combination treatment targeting hormone receptor-positive locally advanc

[News]

Researchers at The Cancer Institute of New Jersey (CINJ) have opened a clinical trial, which aims to evaluate a new treatment for breast cancer in combination with one that is already approved for other types of cancers.

More... (http://www.news-medical.net/?id=46956)